BioPharma Dive 2026-01-26 Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
BioPharma Dive 2026-01-26 The formula for biotech success in 2026: Confidence, resilience and funding
BioPharma Dive 2026-01-26 From detection to prevention: How sponsored testing can transform patient outcomes
BioPharma Dive 2026-01-26 The crucial role of raw material selection for success in cell therapy manufacturing
BioPharma Dive 2026-01-23 Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal